Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
STEMart offers comprehensive Biomarker Discovery Services using Targeted LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), a highly sensitive and specific technology for identifying and quantifying biomarkers in complex biological samples. In our laboratory, Targeted LC-MS/MS plays a crucial role in providing accurate and reliable biomarker data, supporting the discovery and validation of biomarkers for disease diagnosis, therapeutic monitoring, and drug development. Our advanced instrumentation ensures that you receive high-quality results with minimal sample preparation, making it a valuable tool for precision medicine and clinical research.
LC-MS/MS operates by separating analytes using liquid chromatography before they undergo mass spectrometric analysis. In targeted biomarker discovery, specific molecules or pathways are selected for quantification, allowing for high precision in detecting low-abundance biomarkers. This approach is widely applied in clinical research, proteomics, metabolomics, and pharmaceutical development, where the accurate identification of biomarkers is essential for understanding disease mechanisms and improving therapeutic outcomes.
Leveraging our expertise in biomarker analysis and the powerful capabilities of Targeted LC-MS/MS, STEMart offers a wide range of services tailored to meet the specific needs of our clients. From biomarker discovery to validation and quantification, our services deliver critical data to support your research and development projects.
We provide precise quantification of targeted biomarkers using LC-MS/MS, offering accurate data for disease diagnosis and therapeutic monitoring.
Our service includes the discovery of novel biomarkers associated with specific diseases, helping researchers to identify new diagnostic and prognostic indicators.
We offer biomarker analysis to evaluate the pharmacodynamic effects of drug candidates, supporting drug development and personalized medicine approaches.
Using targeted LC-MS/MS, we help monitor biomarker levels to assess patient responses to treatments, providing valuable insights for optimizing therapeutic strategies.
Our LC-MS/MS system offers unparalleled sensitivity and specificity, allowing us to detect and quantify even low-abundance biomarkers with high accuracy.
We offer customizable biomarker panels tailored to your research needs, ensuring that your project receives the most relevant and actionable data.
Our biomarker discovery services adhere to regulatory guidelines, ensuring that your data is reliable and meets the necessary standards for clinical research and drug development.
This system combines liquid chromatography with tandem mass spectrometry, providing precise separation and detection of biomarkers in complex biological samples with high sensitivity.
Complementing our LC-MS/MS, this instrument delivers targeted quantification of specific biomarkers with high precision, making it ideal for personalized medicine and clinical research.
This nano-scale liquid chromatography system offers enhanced sensitivity and accuracy, making it particularly effective for detecting low-abundance biomarkers in challenging samples.
STEMart provides high-quality mass spectrometry services tailored to meet the specific needs of our clients. Our experienced specialists use advanced equipment and follow strict quality control measures to ensure accurate and reliable results. Contact us to learn more about our mass spectrometry services and how we can help you achieve your research goals.